ASCO 2021: Updated Results of MONALEESA-3 Show Sustained Overall Survival Benefits With Ribociclib in Advanced Breast Cancer
Benefits were observed across multiple subgroups, including hard-to-treat patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.